¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀü¸³¼±ÇÐȸ 2024 KPS Annual Prostate International Meeting : 2024-03-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÀü¸³¼±ÇÐȸ 2024 KPS Annual Prostate International Meeting : 2024-03-09
±³À°ÀÏÀÚ : 2024-03-09
±³À°Àå¼Ò : ¼­¿ï SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀǽÇ

±³À°ÁÖÁ¦ : 2024 KPS Annual Prostate International Meeting

ÁÖÃÖ±â°ü : ´ëÇÑÀü¸³¼±ÇÐȸ
´ã´çÀÚ : ÇãÀçÀº
¿¬¶ôó : 02-6956-7967  

À̸ÞÀÏ : gaonpco@gaonpco.com

±³À°Á¾·ù : ºñ´¢ÀÇÇаú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í - »çÀüµî·Ï: 3¸¸¿ø(Àü¹®ÀÇ, ¿¬±¸¿ø, °£È£»ç) / ¹«·á(Àü°øÀÇ, Çлý) - ÇöÀåµî·Ï: 4¸¸¿ø(Àü¹®ÀÇ, ¿¬±¸¿ø, °£È£»ç) / ¹«·á(Àü°øÀÇ,Çлý) - ¿Ü±¹ÀÎ Âü¿©ÀÚ: ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 09:00~10:00 Prostate cancer, etc Á¶¹®±â(¿øÀڷº´¿ø)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:00~10:20 Surgery as radical local treatment (as part of a multimodality approach) Á¶Á¤±â(ÇѾçÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:20~10:40 Radiation therapy as radical local treatment (as part of a multimodality approach) ±¸±³Ã¶(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:40~11:00 Neoadjuvant Lutetium therapy before RP in high risk PCa patients Nathan LAWRENTSCHUK(University of Melbourne)

Åä·Ð 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 11:00~11:10 Case-Based Panel Discussion : Presentation Case 1, 2 °­µ¿Çõ, ÀÌÁ¾¼ö, ¼­¿øÀÍ, ÃÖ¼¼¿µ(ÀÎÇÏÀÇ´ë, ¿¬¼¼ÀÇ´ë, ÀÎÁ¦ÀÇ´ë, Áß¾ÓÀÇ´ë)

ÈÞ½Ä 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 11:10~11:25 Coffee Break ()

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 11:25~11:45 A quest for consensus on focal therapy for prostate cancer Rafael SANCHEZ-SALAS(McGill University in Montreal, Quebec)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 11:45~12:05 Focal therapy in prostate cancer: Friend or Foe Behfar EHDAIE(Memorial Sloan-Kettering Cancer Center)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 12:05~12:25 How should clinicians confirm if a patient is a candidate for focal therapy and define successful treatment? ÀÌÇйÎ(¼­¿ïÀÇ´ë)

Åä·Ð 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 12:25~12:45 Case-Based Panel Discussion : Presentation Case 1, 2 ÀÌÁ¤¿ì, ½Åµ¿È£, ±èÅÂÈ¿, ¼ÛÇÊÇö(°æÈñÀÇ´ë, °¡Å縯°üµ¿ÀÇ´ë, µ¿¾ÆÀÇ´ë, ¿µ³²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 12:45~13:00 Optimal choice in the 1st line mHSPC treatment with apalutamide Á¤°æÁø(°¡ÃµÀÇ´ë)

½Ä»ç 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 13:00~13:45 lunch ()

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 13:45~14:00 Prostate International: past, present, and future Á¤Àç½Â(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 14:00~14:20 CRPC: How to best sequence therapies in real life Daniel DANILA(Memorial Sloan-Kettering Cancer Center)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 14:20~14:40 Current role of PSMA-based radioligand therapy for mCRPC ¹ÚÀ翵(°í·ÁÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 14:40~15:00 The advent of PARP inhibitors for specific to all-comer application- 1) only for specific patients ¼Û¿Ï(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:00~15:20 The advent of PARP inhibitors for specific to all-comer application- 2) for all-comer patients Á¤À翵(±¹¸³¾Ï¼¾ÅÍ)

ÈÞ½Ä 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:20~15:35 Coffee Break ()

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:35~15:55 Laser and robotics enucleastion ¼Û»óÈÆ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:55~16:15 Vaporization and aqua-ablation ±è¸í(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 03¿ù 09ÀÏ SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ1Ãþ ±¹Á¦È¸ÀÇ½Ç 16:15~16:35 Should we abandon TURP? Stavros GRAVAS(University of Cyprus )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀü¸³¼±ÇÐȸ 2024 KPS Annual Prostate International Meeting : 2024-03-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõ±¤¿ª½ÃÀÇ»çȸ °³¿øÀǸ¦ À§ÇÑ Chat GPT ¿¬¼ö°­Á : 2024-03-09
´ÙÀ½±Û Á¦67Â÷ ´ëÇѺñ°úÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-03-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
240 ¼­¿ï ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ International Colorectal Research Summit 2018 : 2018-09-09 0 470 2018-07-28
239 ºÎ»ê µ¿¾Æ´ëÇб³ÀÇ·á¿ø Á¦ 1ȸ µ¿¾Æ´ëÇб³ Á¤Çü¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-09 0 1,154 2018-07-28
238 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018 SNU Orthopaedic Update(III) Foot & Ankle : 2018-09-09 0 939 2018-07-28
237 ºÎ»ê ¼¼ºê¶õ½ºº´¿ø 70Â÷ fresh cadaver shoulder arthroscopy workshop : 2018-09-09 0 458 2018-07-28
236 ºÎ»ê ´ëÇѽÅÀåÇÐȸ ºÎ¿ï°æ Ç÷¾×Åõ¼® ½ÉÆ÷Áö¾ö : 2018-09-09 0 1,224 2018-07-28
235 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø °íÀ§Çè »ê¸ð/½Å»ý¾ÆÀÇ Ã³Ä¡ ¹× °£È£ : 2018-09-09 0 461 2018-07-28
234 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¼¼ºê¶õ½º ¾È°ú 133Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2018-09-09 0 633 2018-07-28
233 °æ±â ¼øõÇâ´ëÇб³ºÎõº´¿ø ³»½Ã°æ ÃÊÀ½ÆÄ ¶óÀÌºê ½ÉÆ÷Áö¾ö 2018 : 2018-09-09 0 982 2018-07-28
232 ¼­¿ï 2018 ´ëÇѹ̿뼺Çü·¹ÀÌÀúÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-09 0 3,304 2018-07-28
231 ¼­¿ï Á¦ 19ȸ ´ëÇÑÅõ¼®Çùȸ Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-09 0 864 2018-07-28
230 ¼­¿ï ÀÌ´ë¸ñµ¿º´¿ø »êºÎÀΰú Áö¿ªÀÇ»ç °£´ãȸ : 2018-09-08 0 687 2018-07-28
229 Á¦ÁÖ ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ CAMP(Chronic Airway Management in Pulmonary disease) ½ÉÆ÷Áö¾ö : 2018-09-08 0 635 2018-07-28
228 ¼­¿ï 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/08 : 2018-09-08 0 611 2018-07-28
227 ¼­¿ï 2018³â À»Áö´ëÇб³ À»Áöº´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-08 0 1,203 2018-07-28
226 ¼­¿ï 2018³â ´ëÇѳëÀθ¶ÃëÅëÁõÇÐȸ Çмú´ëȸ : 2018-09-08 0 579 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷